It has been recently revealed in a report that despite the possibility that the people who are vulnerable with low immunity and suffering from cancer already are at a high chance of suffering from Tamiflu, the actual consequences of the same are unknown for now.

Recent reports have found that a first-line treatment for ovarian cancer, known as Roche's Avastin, is now available in the United Kingdom. The drug would act as a standard treatment in combination with the chemotherapy and surgery.

As per reported information, the Cochrane Collaboration has blamed pharmaceutical giant Roche for withholding information in regard to its swine flu pandemic drug Tamiflu. Earlier, in 2009 a review got published in the British Medical Journal about Tamiflu.

It has been revealed that Roche has filed regulatory submission for vemurafenib with the US Food and Drug Administration and the European Medicines Agency for approval to be used for people with BRAF V600 mutation-positive metastatic melanoma. Moreover, it has submitted an application for the approval for a companion diagnostic.

The debate over the two different treatments of macular degeneration, Avastin and Lucentis, is continuing as new research figures emerge. A study suggests that the significantly cheaper drug Avastin is just as effective as the more expensive Lucentis to stop progressing blindness.

According to a recent report published by Roche's US arm Genentech, the use of the drug Avastin (Roche Institut) to treat vision problems can cause more side effects than taking Lucentis, a drug produced by the same lab.

On Friday, Food and Drug Administration approved the use of Roche Holding AG's rheumatoid arthritis drug, Actemra to treat a rare type of arthritis in children.

Roche has revealed about the success of an experimental drug which can prove to be a boon for the patients suffering from cancer. The drug is instrumental in blocking a protein that the gene produces in the cancerous cells.

In order to give a tough competition to Roche Holding AG's antiviral flu drug Tamiflu, GlaxoSmithKline PLC has also developed a similar drug naming intravenous zanamivir, which is soon to start with its pilot study.

If U. S. and EU regulators invalidate the commercialization of Avastin as a treatment for breast cancer, it will hardly hit the sales of drug maker Roche Holding AG.